Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02393157
Title Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL (O-ICE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors New York Medical College
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
New York Medical College Recruiting Valhalla New York 10595 United States Details
*Shaded cells indicate that there was no data available from for the field